Comparison of neoadjuvant and adjuvant chemotherapy for upper tract urothelial carcinoma in real-world practice: a multicenter retrospective study (Aug, hyad118, 2023)

被引:0
|
作者
Yayoi, Jikei
机构
关键词
D O I
10.1093/jjco/hyad129
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1217 / 1217
页数:1
相关论文
共 50 条
  • [31] A novel signature to predict the neoadjuvant chemotherapy response of bladder carcinoma: Results from a territory multicenter real-world study
    Li, Huihuang
    Hu, Jiao
    Zu, Xiongbing
    Chen, Minfeng
    Chen, Jinbo
    Zou, Yihua
    Deng, Ruoping
    Qin, Gang
    Li, Wenze
    Tang, Jiansheng
    Deng, Dingshan
    Liu, Jinhui
    Cheng, Chunliang
    Cui, Yu
    Ou, Zhenyu
    FRONTIERS IN GENETICS, 2022, 13
  • [32] Neoadjuvant tislelizumab combined with chemotherapy in locally advanced oral or oropharyngeal squamous cell carcinoma: a real-world retrospective study
    Wu, Wen-Jie
    Liu, Qian
    An, Pu-Gen
    Wang, Lin
    Zhang, Jian-Yun
    Chen, Yan
    Zhang, Tong
    Zhang, Jie
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [33] Neoadjuvant Chemotherapy or Neoadjuvant Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: Real-World Data Comparison from A Japanese Nationwide Study
    Okamura, Akihiko
    Watanabe, Masayuki
    Okui, Jun
    Matsuda, Satoru
    Takemura, Ryo
    Kawakubo, Hirofumi
    Takeuchi, Hiroya
    Muto, Manabu
    Kakeji, Yoshihiro
    Kitagawa, Yuko
    Doki, Yuichiro
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (09) : 5885 - 5894
  • [34] Comment on "Neoadjuvant Chemotherapy or Neoadjuvant Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: Real-World Data Comparison from a Japanese Nationwide Study"
    Gronnier, Caroline
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (05) : 2815 - 2817
  • [35] Selected High-Risk Patients With Upper Tract Urothelial Carcinoma Treated With Radical Nephroureterectomy for Adjuvant Chemotherapy: A Multi-Institutional Retrospective Study
    Ikeda, Masaomi
    Matsumoto, Kazumasa
    Hirayama, Takahiro
    Koguchi, Dai
    Murakami, Yasukiyo
    Matsuda, Daisuke
    Okuno, Norihiko
    Utsunomiya, Takuji
    Taoka, Yoshinori
    Irie, Akira
    Iwamura, Masatsugu
    CLINICAL GENITOURINARY CANCER, 2018, 16 (03) : E669 - E675
  • [36] Neoadjuvant platinum-based chemotherapy (NAPC) for metastatic penile squamous cell carcinoma (PSCC): An international, multicenter, real-world study
    Chahoud, J.
    Mustasam, A.
    Rose, K. M.
    Spiess, P. E.
    Moses, K. L.
    Master, V. A.
    Nazha, B.
    Zhuang, T. Z.
    Schneider, A.
    Marchetti, K.
    Roussel, E.
    Pham, R. T.
    Zacharias, N.
    Pagliaro, L.
    Hernandez, C.
    Montrose, J.
    Alifrangis, C.
    Albersen, M.
    Protzel, C.
    Pettaway, C.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1143 - S1143
  • [37] A retrospective real-world study of disitamab vedotin combined with tislelizumab versus chemotherapy in patients with previously untreated metastatic urothelial carcinoma.
    Se, Han
    Gui, Xiaomeng
    Wang, Lin
    Jing, Jing
    Si, Riguleng
    Li, Haojing
    Lv, Dongchen
    Li, Jia
    Chi, Ning
    Li, Sanxiang
    Yang, Hong
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [38] Real-world (RW) characteristics and outcomes in patients (pts) with muscle-invasive urothelial carcinoma (MIUC) treated with adjuvant nivolumab (NIVO) with or without neoadjuvant chemotherapy (NAC)
    Ebrahimi, H.
    Barragan-Carrillo, R.
    John, W. S.
    Lucht, S.
    Miller, T.
    Pathak, P.
    Bland, E.
    Gordon, S.
    Laney, J.
    Klink, A. J.
    Feinberg, B. A.
    Singh, N.
    Alonso, C.
    Patel, M.
    Rosenblatt, L. C.
    Yin, X.
    Chehrazi-Raffle, A.
    ANNALS OF ONCOLOGY, 2024, 35 : S1152 - S1152
  • [39] Adjuvant IO therapie and recurrence treatment in adult patients with urothelial carcinoma. A retrospective, non-interventional study in a real-world cohort
    Hilser, T.
    Darr, C.
    Kirchho, F.
    Seitzer, K.
    Paffenholz, P.
    Zschabitz, S.
    Ivanyi, P.
    Rausch, P.
    Gruenwald, V
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 322 - 322
  • [40] Efficacy, safety, and survival of neoadjuvant immunotherapy plus chemotherapy in locally advanced esophageal squamous cell carcinoma: A real-world retrospective study
    Guo, Yiyu
    Xu, Xinyu
    Wang, Tian
    Liu, Ying
    Gu, Dayong
    Fang, Ying
    Wang, Qiang
    Shi, Haifeng
    Wu, Daguang
    Zhang, Zhi
    Zhou, Guoren
    Ye, Jinjun
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 138